Showing 61 - 80 results of 212 for search '"cystic fibrosis"', query time: 0.10s Refine Results
  1. 61

    Predictors of frequency of CF care in the US Cystic Fibrosis Foundation Patient Registry. by Alexandra C Hinton, Edmund H Sears, Jonathan B Zuckerman, Sara Lopez-Pintado

    Published 2024-01-01
    “…<h4>Introduction</h4>Prolonged gaps in care of >12-months are frequent among people with cystic fibrosis (pwCF) and are associated with reduced lung function. …”
    Get full text
    Article
  2. 62

    Serum Hepcidin Level as a Marker of Iron Status in Children with Cystic Fibrosis by Monika Kałużna-Czyż, Urszula Grzybowska-Chlebowczyk, Halina Woś, Sabina Więcek

    Published 2018-01-01
    “…Material and Methods. 46 children with cystic fibrosis and 31 healthy controls were enrolled. …”
    Get full text
    Article
  3. 63
  4. 64
  5. 65

    Metastatic Bladder Cancer Presenting with Persistent Hematuria in Young Man with Cystic Fibrosis by Premal Patel, Harvey R. Rabin, Michael M. Vickers, Michael D. Parkins

    Published 2013-01-01
    “…We report a case of metastatic bladder cancer developing in a young man with cystic fibrosis (CF) that was initially diagnosed as ureterolithiasis and managed as renal colic. …”
    Get full text
    Article
  6. 66

    Scoping review: relationship between glucose tolerance and pulmonary decline in cystic fibrosis by Raina Tomoda, Deborah Jane Holmes-Walker

    Published 2024-10-01
    “… Cystic fibrosis-related diabetes (CFRD) causes deterioration of cystic fibrosis (CF) lung disease, thereby increasing mortality. …”
    Get full text
    Article
  7. 67

    Additive Effect of Dornase Alfa and Nacystelyn on Transportability and Viscoelasticity of Cystic Fibrosis Sputum by Feng Sun, Shusheng Tai, Thomas Lim, Ulrich Baumann, Malcolm King

    Published 2002-01-01
    “…OBJECTIVE: To investigate the effect of dornase alfa (DA), Nacystelyn (NAL) and their combination on mucociliary transportability and mucus viscoelasticity of cystic fibrosis (CF) sputum, and to assess whether the combination possesses an additive effect.…”
    Get full text
    Article
  8. 68

    Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease by Alexander L. Pukhalsky, Galina V. Shmarina, Nikolai I. Kapranov, Svetlana N. Kokarovtseva, Daria Pukhalskaya, Natalia J. Kashirskaja

    Published 2004-01-01
    “…BACKGROUND and aim: Macrolide antibiotics are widely used in the treatment of suppurative lung diseases including cystic fibrosis (CF), the most common inherited fatal disease in the Caucasian population. …”
    Get full text
    Article
  9. 69

    Efficacy of melatonin treatment in a cystic fibrosis mouse model of airway infection by Kristen R. Schaefer, Sara Rogers, Zachary Faber, Thomas J. Kelley

    Published 2025-01-01
    “…Abstract Approaches to mitigate the severity of infections and of immune responses are still needed for the treatment of cystic fibrosis (CF) even with the success of highly effective modulator therapies. …”
    Get full text
    Article
  10. 70

    Improvement of nutrient absorption may enhance systemic oxidative stress in cystic fibrosis patients by Galina V. Shmarina, Alexander L. Pukhalsky, Svetlana N. Kokarovtseva, Daria A. Pukhalskaya, Elena A. Kalashnikova, Nikolaï I. Kapranov, Natalia J. Kashirskaja

    Published 2001-01-01
    “…Background: The life expectancy of patients with cystic fibrosis (CF) is largely dependent on the pulmonary disease severity and progress. …”
    Get full text
    Article
  11. 71

    Spirometry-Related Pain and Distress in Adolescents and Young Adults with Cystic Fibrosis: The Role of Acceptance by Annabelle Casier, Liesbet Goubert, Tine Vervoort, Marleen Theunis, Danielle Huse, Frans De Baets, Dirk Matthys, Geert Crombez

    Published 2013-01-01
    “…OBJECTIVE: To investigate the occurrence of spirometry-related pain and distress in adolescents and young adults with cystic fibrosis (CF), and to investigate the role of acceptance of illness in spirometry-related pain and distress.…”
    Get full text
    Article
  12. 72

    Sternum Length and Rib Cage Dimensions Compared with Bodily Proportions in Adults with Cystic Fibrosis by Louis-Philippe Laurin, Vincent Jobin, François Bellemare

    Published 2012-01-01
    “…BACKGROUND: A greater structural expansion of the rib cage in females compared with males has been described in cystic fibrosis (CF) patients; however, conflicting data exist as to whether an elongation of the bony ribs and sternum contributes to this expansion.…”
    Get full text
    Article
  13. 73

    Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment by Morgan T. Sutton, David Fletcher, Santosh K. Ghosh, Aaron Weinberg, Rolf van Heeckeren, Sukhmani Kaur, Zhina Sadeghi, Adonis Hijaz, Jane Reese, Hillard M. Lazarus, Donald P. Lennon, Arnold I. Caplan, Tracey L. Bonfield

    Published 2016-01-01
    “…Cystic fibrosis (CF) is a genetic disease in which the battle between pulmonary infection and inflammation becomes the major cause of morbidity and mortality. …”
    Get full text
    Article
  14. 74
  15. 75

    The effect of triple CFTR modulator therapy and azithromycin on ion channels and inflammation in cystic fibrosis by Suhad Bani Melhim, Lisa E.J. Douglas, James A. Reihill, Damian G. Downey, S. Lorraine Martin

    Published 2024-12-01
    “…Background Inflammation in cystic fibrosis (CF) airways is difficult to treat with well-established regimens often including azithromycin (AZ) as an immunomodulatory drug. …”
    Get full text
    Article
  16. 76
  17. 77

    Noninvasive Methods, including Transient Elastography, for the Detection of Liver Disease in Adults with Cystic Fibrosis by Matthew D Sadler, Pam Crotty, Linda Fatovich, Stephanie Wilson, Harvey R Rabin, Robert P Myers

    Published 2015-01-01
    “…BACKGROUND: Liver disease is the third leading cause of mortality in patients with cystic fibrosis (CF). However, detection of CF-associated liver disease (CFLD) is challenging.…”
    Get full text
    Article
  18. 78

    Toll Like Receptors 4 and 2 Expression in the Bronchial Mucosa of Patients with Cystic Fibrosis by Hans-Peter Hauber, Meri K Tulic, Anne Tsicopoulos, Benoit Wallaert, Ron Olivenstein, Patrick Daigneault, Qutayba Hamid

    Published 2005-01-01
    “…BACKGROUND: Cystic fibrosis (CF) is a lung disease characterized by chronic infection with Gram-negative bacteria Pseudomonas aeruginosa and Gram-positive bacteria Staphylococcus aureus. …”
    Get full text
    Article
  19. 79
  20. 80